Côte d'Ivoire vs Myanmar: Tuberculosis patients living with HIV receiving antiretroviral therapy

Côte d'Ivoire
2,632 patients
in 2021
Myanmar
2,203 patients
in 2021
Côte d'Ivoire rank
23rd
Myanmar rank
26th

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Côte d'Ivoire
  • Myanmar
02.0k4.0k6.0k8.0k200420122021

How they compare

Côte d'Ivoire currently reports 2,632 patients against 2,203 patients in Myanmar, a difference of 429 patients.

That makes Côte d'Ivoire's figure about 1.2 times Myanmar's.

The two have swapped places 2 times across 17 shared years of data; in 2005 it was Côte d'Ivoire ahead.

Côte d'Ivoire ranks 23rd and Myanmar ranks 26th of 183 countries.

Across the 3 decades both report, Côte d'Ivoire averaged higher in 1 and Myanmar in 2.

Head to head by decade

Decade Côte d'Ivoire Myanmar Difference Ahead
2000s 1,027 patients 334.2 patients 693 patients Côte d'Ivoire
2010s 3,306 patients 3,762 patients 456.4 patients Myanmar
2020s 2,695 patients 4,168 patients 1,473 patients Myanmar

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Côte d'Ivoire or Myanmar?
Côte d'Ivoire, at 2,632 patients against 2,203 patients in Myanmar as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Côte d'Ivoire and Myanmar?
429 patients, with Côte d'Ivoire ahead.
How many years of comparable data are there for Côte d'Ivoire and Myanmar?
17 years are reported by both, from 2005 to 2021.
How do Côte d'Ivoire and Myanmar rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Côte d'Ivoire ranks 23rd and Myanmar ranks 26th of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Côte d'Ivoire vs Myanmar: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 13 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/cote-d-ivoire/myanmar/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/cote-d-ivoire/myanmar/">Côte d'Ivoire vs Myanmar: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.